| FHJUX | UEPSX | FHJUX / UEPSX | |
| Total Expense Ratio | 1.07 | 2.78 | 38% |
| Annual Report Gross Expense Ratio | 1.07 | 3.53 | 30% |
| Fund Existence | 12 years | 27 years | - |
| Gain YTD | 7.645 | 18.815 | 41% |
| Front Load | 6% | N/A | - |
| Min. Initial Investment | 0 | 15000 | - |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 977M | 9.18M | 10,647% |
| Annual Yield % from dividends | 1.76 | 0.76 | 232% |
| Returns for 1 year | 17.72 | 37.09 | 48% |
| Returns for 3 years | 57.79 | 68.22 | 85% |
| Returns for 5 years | 15.00 | 70.40 | 21% |
| Returns for 10 years | 57.35 | 131.34 | 44% |
| 1 Day | |||
|---|---|---|---|
| MFs / NAME | Price $ | Chg $ | Chg % |
| AWSRX | 18.00 | 0.10 | +0.56% |
| Invesco Global Core Equity R | |||
| CSXCX | 56.40 | 0.31 | +0.55% |
| Calvert US Large Cap Core Rspnb Idx C | |||
| IVRIX | 32.63 | -0.21 | -0.64% |
| VY® Columbia Real Estate I | |||
| VRTGX | 515.99 | -3.55 | -0.68% |
| Vanguard Russell 2000 Growth Index I | |||
| SHPAX | 22.87 | -0.25 | -1.08% |
| Saratoga Health & Biotechnology A | |||